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ABSTRACT
Tea (Camellia sinensis, Family: Theaceae) is one of the extremely consumed beverages around the world, behind to water. The brew tea is the merely food 
product contains abundant quantity of the catechins. Green tea is the least processed and thus contains rich antioxidant, polyphenols, especially catechin 
called epigallocatechin-3-gallate (EGCG), which is whispered to be responsible for a wide range of the health benefits. The key to the amazing health benefits 
that are derived from green tea is that the leaves are steamed which preserves the EGCG compound from being oxidized. However, the other varieties of teas 
are under go fermentation process, which breaks down the potential EGCG and destroy from its healing properties. In reality, green tea has very extensive 
history dating back thousands and thousands of years ago. However, the pharmacological efficacy and stability of green tea catchiness are primarily depended 
on the formulation and way to drink to alleviate the deadly diseases with scientific evidence. Nanotechnology is a vibrantly emerging field especially in the 
pharmaceutical industry to explore a lot of application. The promising nano-delivery system used to enhance the therapeutic efficacy with a minimal dose, 
minimize the dose-related toxicity, target delivery, site-specific delivery, and controlled/sustain the delivery application. In recent decades, the application of 
nanotechnology has been utilized for phytopharmaceutical industry including green tea catechins to maximize the health benefits. In this review, we tried our 
level best retrieve the value of information on nanodelivery application of green tea catchiness for various devastating diseases.
Keywords: Camellia sinensis, Green tea, Catechine, Flavonoids, Nanoparticles, Nanoemulsion, Liposomes.
INTRODUCTION
Since the ancient era, herbals and natural products are being used 
to devastate many deadly diseases including cancer, diabetes, 
cardiovascular complications, and psychological disorders. Unlike 
widely used modern medicine, herbal formulations have numerous 
vital phytoconstituents that all work simultaneously to eradicate the 
diseases [1-4]. However, the health benefits of herbal medicines not 
extensively delivered to heal the diseases due to deprived acceptance 
by many physicians, and lack of scientific and clinical evidence [5-7]. 
The majority of the phytoconstituent before get absorbed into the 
systemic circulation, deactivated by a wide range of gastrointestinal 
pH, biological enzymes, and liver metabolism [8-10]. Consequentially, 
the optimum therapeutic outcome of herbal drugs may not attain. If the 
drug does not achieve the optimum concentration to the affected region 
at “minimum effective level,” then there will be no therapeutic outcome 
of the drug. During recent decades, nano drug delivery technology 
has been utilized for a wide range of pharmaceutical compounds 
to deliver sustains or controlled manner to treat various chronic 
illness [11]. After successful preclinical and clinical research, numerous 
nanoformulations have been existed to alleviate various chronic illness 
and cosmetic applications [12,13].
Tea (Camellia sinensis, Theaceae) is one of highly consumed beverages 
around the globe [14-17]. In addition to being the most widely 
consumed tea, it is the only food product known to contain substantial 
levels of the catechins [18,19]. All tea plants belong to the same species 
C. sinensis; but local growing conditions (altitude, climate, and soils) 
vary, resulting in a multitude of distinctive leaves [20,21]. The way the 
leaves are processed, however, is even more important in developing 
the individual characteristics of the three predominant types of tea: 
Green, black, and oolong. Green tea is the least processed and thus 
contains rich antioxidant, polyphenols, remarkably a catechin called 
epigallocatechin-3- gallate (EGCG), which is believed to be accountable 
for most of the health benefits [22-26]. The following catechins are 
abundantly present in green tea including (-)-EGCG ( ̴ 59% from total 
catechins); (-)-EGC ( ̴19% from total catechins); (-)-epicatechin (EC)-3-
gallate ( ̴14% from total catechins); and (-)-EC (6% from total catechins). 
It also carries gallic acid and other phenolic compounds including 
chlorogenic acid and caffeic acid, and flavonols such as myricetin, 
kaempferol, and quercetin [27]. Green tea is made by steaming the 
fresh leaves, rendering them soft, pliable, and preventing them from 
fermenting or changing color [28,29]. After steaming, the leaves are 
rolled, then spread out and dried with hot air until they become crispy. 
The resultant tea has greenish-yellow in color, slightly astringent 
flavor. Green tea is extremely famous beverage in all around the world. 
It not only captures the taste, aroma and color of spring but also 
delivers this delightful bouquet along with the highest concentration 
of beneficial phytoconstituents and the low level of caffeine compared 
to all other teas [30-32]. The key to the amazing health benefits that 
are derived from consuming green tea is that, the leaves are steamed 
which preserves the EGCG compound from being oxidized [33,34]. 
Other varieties of teas are fermented but which rupture the vital 
compound EGCG and spoil its healing ability. In fact, green tea has very 
long historical background since few 1000 years ago.
Nanoparticle is an emerging drug delivery system which has 
applied to the vast majority of herbal phytoconstituents to attain 
greater therapeutic efficacy [35,36]. These delivery systems have 
widespread advantages including enhanced drug loading, protect 
against gastrointestinal pH, escape form first-pass metabolism, 
ability to achieve prolonged release, and improved stability [37-39]. 
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Encapsulation of herbal extracts into nanocarrier system has certain 
added advantages embrace with sustain/controlled drug release, site-
specific drug release, improved enzymatic stability, and increased 
intracellular drug release [40-43]. We have done extensive literature 
review on the health benefits of catechin from green tea extract (GTE) 
and their pharmaceutical and biological challenges toward achieve 
maximum therapeutic potential and also enlighten the application 
of nano drug delivery utilized to improve its pharmacological and 
pharmaceutical attributes.
CHALLENGES OF DEVELOPING GREEN TEA CATECHIN AS 
THERAPEUTIC AGENT
Bioavailability challenges
A major challenge in extrapolate the therapeutic activities of green tea 
polyphenols in vitro to possible effects in vivo bioavailability [44]. The 
deprived bioavailability of EGCG might be attributed to several factors: 
(a) The instability of EGCG in alkaline or neutral condition, (b) low 
cellular uptake due to high aqueous solubility and poor hydrophobicity 
to cross cell membrane; (c) metabolic transformations such as 
methylation, glucuronidation and sulfation [21], and (d) active efflux 
effect of many polyphenolic compounds by the Multidrug Resistance-
Associated Protein 2 [45-50]. Administration of decaffeinated 
green tea to the rats, the plasma bioavailability of EGCG, EGC, and 
epicatechin EC was 0.1%, 14%, and 31%, respectively, compared 
with mice model, whose absolute plasma bioavailability of EGCG was 
26.5% [51]. Numerous researches on the pharmacokinetic profile of tea 
polyphenols in humans have been reported till date [52-55]. The oral 
administration of green tea at dose 20 mg/kg body weight resulted in 
plasma Cmax for EGCG at 78 ng/mL; it was very low to the micromolar 
concentration usually required for in vitro activity. Thus, the extent of 
bioavailability and therapeutic efficacy of GTE primarily depends on the 
route of administration and site of the organ [56-59].
Biological stability of GTE
The EGCG is unstable phytoconstituent which is effortlessly prone to 
oxidation reaction. The researcher Friedman reported that EGCG on 
green tea showed a decrease in EGCG concentration after stored at the 
dry condition at 20°C during 6 months due to the oxidation process [60]. 
TCs as a mixture in alkaline solutions (pH > 8) were highly unstable and 
degraded almost completely within a few minutes, whereas in acidic 
solutions (pH < 4) it was highly stable. From the pH 4–8, the stability of 
GTCs was pH-dependent, i.e., the lower the pH, the greater, the stability. 
Four EC isomers demonstrated varying stability in alkaline solutions 
with EGCG and EGC being equally instable, and EC and ECG being 
relatively stable [61-64].
Stability issues during green tea processing
It is well documented that polyphenol exists in tea is responsible for 
health-related beneficial effects. The content and stability of the tea 
polyphenols mostly depend on several production parameters including 
vascular plant, harvesting season, age of the plant, environmental 
condition, and process condition. It is well documented that process 
condition is one of the vital factors that determine the quality of the 
tea product [65].
On the other hand, EGCG is unstable to light and warm condition. The 
degradation temperature for EGCG is 85°C while exposed to radiation 
for 1 h. Therefore, infundation extraction method should be performed 
in extreme cold condition and the pH is adjusted to 4 using phosphoric 
acid [66]. This treatment could increase EGCG concentration much 
higher in methanolic solution, while the green tea after infundation 
process that underwent the temperature decreasing process until 
22°C showed that EGCG concentration was 30% lower than methanol. 
Green tea that underwent 90°C infundation method during 30 min 
without pH alteration exhibited similar to methanolic solvent. This 
study reported that the importance of extreme decreasing temperature 
and decreasing pH to 4 after infundation process and the resultant 
EGCG concentration was 6.7% [67]. Prayong et al., 2007, reported 
that the EGCG concentration was 0.21–9.63% [68], whereas the EGCG 
concentration end in brewed tea was 2.8–3.96% [69]. Besides that, 
EGCG concentration with extreme decreasing temperature and adding 
phosphoric acid till pH 4 was 35% [70]. The second most abundant 
flavonoid present in green tea leaves is catechin. Tea catechins 
undergo degradations and epimerization in the aqueous condition 
during thermal processing. It is known that thermal degradation and 
epimerization of green tea catechins follow pseudo-first-order reaction 
kinetics in the aqueous solvent system [71].
NANO DRUG DELIVERY APPROACH OF GREEN TEA
EGCG offers enormous health benefits since it is ample accessible 
and inexpensive to extract and isolate from the tea leaf; it may be 
administered orally and proven safety profile. The usage of EGCG in 
clinical practice was greatly hampered due to diminutive half-life, short 
stability, and less bioavailability [71]. The stability issues of orally 
ingested EGCG were evidenced that the detected plasma concentration 
was recorded very poor (0.2–2%). In addition, the effective antitumoral 
concentration of EGCG in vitro is generally an order of magnitude higher 
than the levels measured in vivo, which restricts its effectiveness [72]. 
Moreover, EGCG has poor target specificity. Therefore, a technique 
that will increase the EGCG stability, bioavailability, and cell-
specific delivery is highly important to attain maximum therapeutic 
efficacy. Recently, the nano delivery technique was introduced to 
enhance the pharmacokinetic and pharmacodynamic of the efficacy 
of chemotherapeutic agents to inhibits, slow-down, or revert the 
cancers. The encapsulation of EGCG into a specific nanocarrier can 
increase its solubility and bioavailability, protect it from premature 
degradation, provide prolonged circulation time and induce higher 
levels of target specificity [73-76]. Polymeric nanoparticles have a 
promising delivery system in the field of the biomedical field due to 
its biocompatibility, biodegradability, possibility to control the rate of 
polymer degradation and release rate, mechanical strength, and high 
structure versatility [77,78]. With these positive prospects, the various 
polymeric nanoparticulate drug delivery systems have been developed 
and investigated to enhance the therapeutic potential of green tea 
polyphenols. In this review paper, we tried our level best to extract and 
compiled the most vital information related to the nano delivery and its 
application toward green tea polyphenols.
Chitosan nanoparticles (CSNP)
Catechins found in tea leaf have gained significant attention as a result of 
their favorable pharmacological properties including cardioprotective, 
neuroprotective, and anticancer effects [79]. However, their therapeutic 
prospects are hampered due to their deprived oral bioavailability, poor 
stability, and intestinal absorption. To enhance the oral bioavailability, 
(+)-catechin (C) and (-)-EGCG were encapsulated into CS-NP drug 
delivery system. Victimization excised mouse small intestine in 
victimization chambers, encapsulation considerably increased 
(p<0.05) internal organ absorption. The additive amounts transported 
after encapsulation were significantly higher, i.e., 302 versus 
206 ng/cm and 100 versus 58 ng/cm for C and EGCG, respectively. The 
mechanism of enhanced absorption was not through an impact of CS-
NPs on internal organ either paracellular or transcellular transport 
mechanism. However, it was possible as a result of the stabilization of 
catechins after encapsulated into CSNP [80]. The researcher Alotaibi 
et al., 2013, also encapsulated EGCG into Poly (lactic-co-glycolic acid) 
(PLGA) based polymeric nanoparticles and investigated the effect of 
DNA damage against lymphocytes of healthy and colorectal cancer 
patients pretreated with oxaliplatin of satraplatin. The obtained results 
concluded that the PLGA encapsulated EGCG significantly intensified 
DNA damage levels in a dose-dependent manner. In contrast, free EGCG 
promoted a reduction in DNA damage [77].
Solid lipid nanoparticles (SLN)
Manea, Ana-Maria et al., 2014, developed GTE loaded SLN by high shear 
homogenization technique and investigated the antioxidant potential 
and antimicrobial activity. The antioxidant efficacy of GTE loaded SLNs, 
was higher than free-SLNs or GTE in bulk as a result of a synergistic 
effect between the complex structural lipid matrix and bioactive GTE 
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encapsulated. The use of the two surfactants Tween 20 and Tween 
80, as well as two different concentrations of GTE (0.1 and 0.17%), 
and did not produce any significant variation. The highest antioxidant 
(99.6%) was obtained when Tween 20 was used as a surfactant and the 
concentration of GTE (0.17%), while the less antioxidant (87.3%) was 
exhibited when Tween 80 used as a surfactant and the concentration of 
GTE was 0.1% [81].
Green tea catechins constitute about 8–15% of total dry tea weight. 
The most abundant catechin is EGCG, which accounts for 25–55% of 
total catechins. One cup of green tea made using a 2.5 g tea bag contains 
about 100 mg of EGCG [82,83]. Consumption of EGCG has been reported 
to have several health benefits including antioxidant, anti-inflammatory, 
anti-tumorigenic, and antiangiogenic properties as established by Chyu 
et al., 2004 [84].
De Pace et al., 2013, developed EGCG loaded into liposomes and 
chitosan-coated liposomes, with the vesicular size ≤100 nm in diameter 
to enhance the stability. The nanoliposomal delivery system has been 
drastically enhanced the stability of EGCG in both phosphate-buffered 
saline and Eagle’s minimum essential (EME) cell culture medium. The 
free EGCG in EME medium was completely degraded after 8 days at 4°C. 
However, EGCG loaded liposomes and chitosan-coated liposomes were 
degraded 62% and 38%, respectively, at the same conditions and initial 
concentrations. After 1-h incubation at 37°C, the EGCG degradation 
rates of 0.5 mM of free EGCG, EGCG loaded liposomes, and chitosan-
coated EGCG loaded liposomes in EME medium were 100%, 46%, and 
32%, respectively [85].
It is well established that EGCG has not readily absorbed in humans 
and animal models. The Barras et al., 2009, had conducted the 
pharmacokinetic and bioavailability investigation of tea leaf catechins 
using rat models. The plasma peak concentrations of green tea catechins 
exhibit at 2–4 h after oral administration. The absolute bioavailability 
of EGCG after intragastric administration of decaffeinated green tea is 
about 0.1% in rats [86]. Consistent with this result, the bioavailability 
of EGCG is 0.14% in males and females after consumed tea which 
contains 400 mg catechins for 24 h period. The peak plasma EGCG 
concentration is around 0.15 µM after drinking two cups of green 
tea. A majority of published cell culture studies have used EGCG at 
physiologically irrelevant concentrations in the range of 10–200 µM. 
Since EGCG at lower, and physiological relevant (achievable by oral 
administration) concentrations have little or very limited efficacy and 
thus, it is highly important to enhance the EGCG bioavailability, and the 
nanoparticulate drug delivery technology appears to be an appropriate 
concept to address these issues [87]. In fact, numerous researches 
revealed that nanoencapsulation system has been one of the prominent 
nano delivery systems which significantly increases EGCG stability and 
improves drug release rate, which partially contributes to the increased 
cellular uptake of EGCG. In another research reported that the chitosan-
based nanoparticulate systems have capable to enhance the EGCG 
bioavailability [87-90]. Dube et al., 2013, compared the intestinal 
absorption of free EGCG and nano-EGCG (CSNP) using excised mouse 
jejunum. They added 50 µM of free and nano-EGCG in the mucosal 
chambers and collected the transported EGCG in the serosal chambers 
after 3 h time interval, and found that nano-EGCG had about two-fold 
higher accumulative transported than free EGCG. The enhanced stability 
of EGCG and improved transcellular transport process was achieved in 
nanoparticle system, but not paracellular transport mechanism, may 
partially contribute to the enhanced intestinal absorption [91]. After 
reaching the apical membrane of intestinal epithelial cells, most of 
the nanoparticles cross enterocytes through transcellular transport 
mechanism. Nanoparticles are internalized into enterocytes and 
then transported across enterocytes. The particle size ≤500 nm in 
diameter is internalized through both clathrin- and caveolae-mediated 
endocytosis. The process of endocytosis can be enhanced by modifying 
nanoparticles, for example, by coating with polyethylene glycol or 
positive charges on the surface of nanoparticles [80]. The researcher 
Dube et al., 2013, measured the plasma concentrations of EGCG in mice 
after oral administration of either free EGCG or EGCG encapsulated 
CSNP. Compared to free EGCG, EGCG-loaded CSNP increased plasma 
EGCG concentrations by a factor of 1.5 [46]. EGCG nano lipidic particles 
increased the oral bioavailability by ≥2 folds as compared to free EGCG 
in rats as documented by Wang et al., 2013 [87].
Gold nanoparticles for tumor targeting
The tea based gold nanoparticles (T-AuNPs) [93] have evidenced 
remarkable in vitro stability in various buffer solution including saline, 
histidine, HSA, and cysteine solutions. T-AuNPs with phytochemical 
coatings have shown important affinity toward prostate (PC-3) and 
breast cancer (MCF-7) cells. This study reported on the cellular 
acquisition of T-AuNPs through endocytosis into the PC-3 and MCF-
7 cells. The T-AuNPs follows all principles of green chemistry and are 
found to be non-cyanogenic as evaluated by MTT assays. This true 
biogenic green nanotechnological process T-AuNPs paving excellent 
opportunities for their applications in molecular imaging and clinical 
therapy [94].
Several reports have described the results of gold NPs in conjugation 
with EGCG for cancer treatment. The AuNPs loaded with EGCG (EGCG-
pNG) prepared by ultrasonication technique and investigated their 
effect in the treatment of bladder cancer both in vitro and in vivo [95]. 
Their results shown that this strategy induced high levels of cytotoxicity 
in bladder cancer cells (MBT-2) without affecting the viability of normal 
cells (Vero cells). Treatment with EGCG-pNG was shown to induce 
apoptosis through triggering the intrinsic apoptotic pathway through 
the activation of caspases-3 and caspases-7 and these were confirmed 
by in vivo studies. C3H/HeN mice subcutaneously implanted with MBT-
2 cells revealed significant higher reduction in tumor volume after 
oral ingestion of EGCG-pNG in comparison with free EGCG. In addition 
to this, nanoparticles were also administered through intratumoral 
and intraperitoneal route. These routes of administration were more 
effective than oral administration in suppressing tumor growth. The 
in vitro results showed that gold NPs induced nearly five-fold higher 
levels of apoptosis in B16F10 murine melanoma cells compared to non-
encapsulated EGCG. The in vivo results demonstrated that intratumoral 
injection of EGCG NPs induced a reduction in the tumor volume of a 
mouse melanoma model compared with the control group. This 
ability to inhibit tumor growth was 1.6 times higher when EGCG was 
encapsulated compared to free EGCG [95].
PLGA/PEG nanoparticles
The EGCG encapsulated with polylactic acid–polyethylene glycol 
nanoparticles and found that encapsulated EGCG retains its biological 
effectiveness with over 10-folds dose. The advantage for exerting 
its proapoptotic and growth suppressive effect, critically important 
determinants of chemopreventive effects of EGCG in both in vitro and 
in vivo systems. Hence, this study could serve as a basis for the use of 
nanoparticle-mediated delivery to enhance bioavailability and limit the 
toxicity of chemopreventive agents, such as EGCG [73].
Nanospheres for bioavailability enhancement
Nano BioSpheres Delivery System produced by the proprietary method, 
they are taken up more readily by cells than larger particles. Nanospheres 
are very small particles, measured in nanometers (nm), or billionths of 
a meter, that are now burgeoning into nutrient-delivery systems with 
diameters as small as 50 nm or even lower. Those showing greater 
efficacy are made of natural lipids, in which lipophilic compounds, such 
as the nutrients mentioned above, can readily dissolve [96].
Liposomes
Liposomes are vesicular drug delivery system forming a membrane-
like phospholipid bilayer enclosing an aqueous compartment. This 
vesicular delivery system facilitates to encapsulate both lipophilic and 
hydrophilic drugs with higher concentration. In addition, liposomes 
are biodegradable and present minimal levels of toxicity due to the 
biodegradable nature of the phospholipid membrane [97,98]. Fang 
et al., 2006, developed liposomes with EGCG for topical and intratumoral 
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delivery to treat BCC (basal cell carcinoma) in female nude mice. The 
authors concluded that intratumoral injection of liposomes was the 
most effective route to succeed in cancer cells, promoting an excellent 
quantity of EGCG deposition in neoplastic cells. The same research 
group has also reported the applications of liposomal formulations for 
BCCs treatment in vivo after intratumoral administration. According 
to the authors Fang et al., 2006, that the nanoencapsulation of EGCG 
significantly increased the stability as compared to free drug, which may 
indicate that liposomes protect EGCG against oxidation and degradation. 
The synthesized liposomes also enabled higher EGCG accumulation in 
tumor tissues and induced higher levels of BCC cell death compared to 
the non-encapsulated EGCG treatment at lower concentrations [99].
Rashidinejada et al., 2014, encapsulated tea catechin and EGCG in soy 
phospholipid liposomes was examined at four different concentrations 
(0%, 0.125%, 0.25%, and 0.5% w/v), and inclusion in cheese at 1/3 and 
0.25% w/v. The empty capsules had a mean diameter of 133 nm and 
considerably (p<0.05) enlarged with the addition of catechin or EGCG. 
The microscopical investigation disclosed the lamellae and central 
core of the liposome and addition of antioxidants gave a big (p<0.05) 
increase within the size of liposomes. Liposome’s had zeta potentials 
value in the range between −42.4 and −46.1 mV with no vital distinction 
between treatments, suggesting stable vesicle systems. High potency 
(>70%) and yield (∼80%) were achieved from the incorporation of 
catechin or EGCG within the vesicle structure [100].
Phytosomes
A phytosome is class of vesicular delivery system utilized to encapsulate 
the herbal extracts or isolated active principles with a phospholipid 
bilayer system used to administer both topically as well as orally. To 
overcome the low bioavailability and poor oral absorption of EGCG, Kazi 
Kazi et al., 2016, had formulated the catechin loaded nano phytosomes, 
newly acquainted forms of herbal formulations, with better bioavailability, 
entrapment efficiency, and stability using quality by design approach 
[101]. Catechins were extracted from green tea leaves using an aqueous 
solvent system at various temperature conditions. The concentration of 
EGCG in the extracted catechins was determined using ultra-performance 
liquid chromatography (UPLC) method. The obtained result from UPLC 
showed that 500 µg/ml EGCG was present in GTE. Particle size distribution 
data showed that phytosomes were in the range of 130–270 nm when 
characterized using Malvern Zetasizer and microscopic method. The rate 
and concentration of phospholipid were identified as critical process 
parameters and critical material attributes, respectively, affecting the 
quality attributes of phytosome. Formulations which proceeded at high 
addition rate exhibited smaller particle size and PDI compared to the 
formulations with low addition rate. The concentration of phospholipid 
has not influenced the particle size of phytosome at buffer pH 5.5, while 
the increased concentration of phospholipid and buffer pH 7 the particle 
size was decreased. The entrapment efficiencies for phytosome were in 
the range of 63–86%, which was related to the size of the phytosomes. This 
study concluded that the phospholipid concentration and addition rate 
have marked an impact on average particle size, PDI, and encapsulation 
efficiency of nano phytosomes [101].
Protein (oligomer) based nanoparticles
IBN nanotechnology researchers have designed a therapeutic 
nanocarrier for drug delivery using novel compounds derived from 
EGCG. The core of this carrier is made of an oligomer of EGCG (OEGCG), 
which can encapsulate drugs and proteins, such as Herceptin, a protein 
drug currently used to treat breast cancer. Polyethylene glycol (PEG)-
EGCG was used to form the shell of this carrier. This novel compound 
is constituted of PEG, which is a known “stealth” polymer which acts to 
increase the circulation time of the carrier system, preventing it from 
being detected and filtered out of the body by the immune system before 
it reaches the tumor cell [102]. Micellar nanocomplexes (≤100 nm 
in dimension) are formed from the OEGCG core and PEG-EGCG shell, 
protecting the protein drug from rapid proteolysis and renal clearance, 
while providing for tumor targeting. The research group conducted 
preclinical studies to evaluate the performance of IBN’s green tea-based 
protein delivery system [103]. The study revealed that IBN’s green 
tea nanocomplex loaded with Herceptin reduced tumor growth much 
more effectively when compared to administering Herceptin on its own. 
Using this nanocarrier, two-fold drug accumulated in the cancer cells, 
indicating an improved tumor targeting ability. At the same time, the drug 
accumulation in the other organs (liver, kidney, and lung) was lowered 
substantially. Green tea-based nanocarrier, in which the carrier itself 
displayed the anticancer effect, can boost the cancer efficacy when used 
together with the protein drugs. Author Motoichi Kurisawa developed 
green tea based nanocarrier drug delivery system to eradicate cancer 
and he had filed a patent for his formulations. The green tea-based 
micellar complexes are also being examined for the delivery of active 
ingredients in personal care and nutritional products [104].
Nanoemulsion system
Nanoemulsion is a suitable delivery system for nutrients to improve 
bioavailability by enhancing internal organ uptake. Kim et al., 2013, had 
established the inhibitory and hypolipidemic effects of nanoemulsified 
green tea extract (NGTE). The inhibitory effect was measured by a pair 
of 2′-azino-bis (3-ethylbenzthiazoline-6-sulfonic acid) (ABTS) radical 
scavenging assay and dichlorofluorescein diacetate (DCFH-DA) assay. 
C57BL/6 mice were fed an impression high-fat diet, GTE, or NGTE diet 
for 4 weeks. In composition analysis, GTE and NGTE contained similar 
total catechin concentrations. The antioxidative impact of GTE was 
comparable that of NGTE within the ABTS assay, GTE had a marked 
impact, though NGTE was more practical than GTE within the DCFH-
DA assay within the mouse feeding experiment, total and low-density 
lipoprotein cholesterin concentrations were considerably reduced 
when NGTE treatment as compared with GTE treatment in high-fat-fed 
C57BL/6J mice over the course of 4 weeks. The hypocholesterolemic 
effects were larger within the NGTE cluster compared with the GTE 
cluster (24% vs. 15.4% cholesterol reduction compared with the 
control). Expression of 3-hydroxy-3-methylglutaryl coenzyme enzyme 
was considerably down-regulated. Super molecule expression of 
beta-lipoprotein receptor was considerably enlarged within the livers 
of each the GTE- and NGTE-treated groups (+234.1%, p<0.01 and 
+274.7%, p<0.001), with a larger impact within the NGTE than within 
the GTE groups. These results suggested that nanoemulsion technique 
considerably promote the hypocholesterolemic efficacy of GTE in vivo 
attributable to enhance bioavailability [105].
Liquid crystalline nanocomposite
A liquid crystalline system (LCS) is a kind of nanostructured system 
accustomed incorporates various bioactive. Liquid crystals are 
identified since 1889, once Lehmann represented AN intermediate 
state within the thermal transformation from solid to liquid state. 
Hence, a striking approach to beat this downside to safeguard the 
GTE is its incorporation into LCS and these drug delivery systems 
with completely different rheologic properties, since LCS have each 
fluid-liquid and crystalline-solid property. The in vivo inflammation 
assay disclosed that the less elastic and consistent LCS, F25E, and 
F32E given statistically constant medication activity compared to the 
positive management, decreasing considerably the paw swelling when 
4 h; whereas, the foremost structured and elastic LCS, powerfully 
restricted the potential effects of GTE. Thereby, the event of drug 
delivery systems with appropriate rheologic properties might enhance 
GTE bioavailability; sanction its administration through the skin for the 
treatment of inflammation [106].
Lipid nanoparticles for cosmetics
In year 2007, Grassland launched the supermolecule mainly based 
nanoparticles of Swiss cellular white illuminating eye essence. 
Swiss cellular white intensive ampoules that contain tea leaf extract, 
glycoprotein, herb root extract, horsetail extract, and viola extract [107].
CONCLUSION
Even though the health benefits of tea products are famed for thousands 
of years, basic analysis findings on its main phytoconstituent, EGCG, have 
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well researched to be extraordinarily promising in various therapeutic 
benefits within the past decades. Moreover, the current data revealed 
that peoples from United States drinking large amounts of tea, or taking 
over-the-counter green tea extract product for desirable health benefits. 
From this review paper, we able to concluded that the potent EGCG has 
exposed to various nano drug delivery systems to improve the stability, 
rate of absorption and bioavailability. The polymeric nanoparticles, 
lipid-based nanoparticles, the vesicular system including liposomes, 
and phytosomes were adopted to develop green tea based products 
especially EGCG compound. The numerous health edges of EGCG as a 
prophylactic, however conjointly as a therapeutic, agent acting through 
totally different pathways are well documented within the literature. 
The conflict between in vitro and in vivo studies could also be thanks 
to its erratic bioavailability. Aspects regarding these facts, however 
conjointly with reference to dose levels, administration frequency and 
potential aspect effects stay to be addressed in future clinical trials.
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